SCHEMBL4496601

SCHEMBL4496601

O=C(Nc1ccc(Cn2cccn2)cc1)c1cc(COc2cccc(C(F)(F)F)c2)ccn1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
KDM4E B2RXH2 2/20 0.60
NPC1 O15118 1/20 0.60
GAA P10253 1/20 0.60
RAB9A P51151 1/20 0.60
LMNA P02545 2/20 0.49
MEN1 O00255 1/20 0.49
HPGD P15428 1/20 0.49
KMT2A Q03164 1/20 0.49
POLB P06746 1/20 0.48
FFAR1 O14842 1/20 0.47
KDR P35968 2/20 0.45
MRGPRX4 Q96LA9 2/20 0.45
PDGFRA P16234 1/20 0.43
S1PR1 P21453 1/20 0.43
S1PR5 Q9H228 1/20 0.43
PLK4 O00444 1/20 0.43
AURKA O14965 1/20 0.43
MAPK13 O15264 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4516601 0.88 MAPT (0.63) MAPTSMN1; SMN2KDM4ENPC1GAA
SCHEMBL4505158 0.87 MAPT (0.64) MAPTSMN1; SMN2KDM4ENPC1GAA
SCHEMBL4508842 0.84 ALDH1A1 (0.52) MAPTSMN1; SMN2KDM4ERAB9ALMNA
SCHEMBL4517237 0.80 MAPT (0.61) MAPTSMN1; SMN2KDM4ENPC1GAA
SCHEMBL4508856 0.80 MRGPRX4 (0.48) MAPTKDM4EGAAFFAR1KDR
SCHEMBL4512260 0.79 SCD5 (0.45) MAPTKDRMRGPRX4PLK4AURKA
SCHEMBL4506513 0.79 SCD5 (0.49) MAPTSMN1; SMN2KDM4EMEN1HPGD
SCHEMBL4503513 0.79 SMN1; SMN2 (0.62) MAPTSMN1; SMN2KDM4ENPC1GAA
Hydrochloric Acid SCHEMBL4496489 0.78 MRGPRX4 (0.47) MAPTKDM4EGAAMEN1KMT2A
SCHEMBL4518670 0.78 MAPT (0.56) MAPTSMN1; SMN2KDM4ENPC1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090325956-A1 Aromatic amine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-12-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090325956-A1 Aromatic amine derivative and use thereof SCD, SCD5, SMS MAPT 4022/4885SMN1; SMN2 2075/4885KDM4E 249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.